News / Health

Antibody Therapy Clears Destructive Alzheimer’s Brain Plaques

This undated image provided by Merck & Co., shows a cross section of a normal brain (right) and one of a brain damaged by advanced Alzheimer's disease, December 3, 2012
This undated image provided by Merck & Co., shows a cross section of a normal brain (right) and one of a brain damaged by advanced Alzheimer's disease, December 3, 2012
Jessica Berman
Scientists say they've developed a type of disease-fighting antibody that, in tests with laboratory mice, is able to clear away the destructive brain plaques, or protein deposits, believed to cause Alzheimer’s Disease.  Researchers note that while several experimental drugs have shown promise in preventing plaque development, this new antibody therapy is the first to successfully remove existing plaques, suggesting a possible treatment for Alzheimer's patients. 

By the time most people visit their doctors complaining of serious memory problems and cognitive decline, experts say their brains very likely are already riddled with sticky deposits of amyloid beta protein. These plaques are the hallmark of Alzheimer's, a progressive neurodegenerative disease that eventually leads to disability and death. According to Alzheimer’s Disease International, in 2010 there were an estimated 35.6 million people around the world suffering from various forms of dementia, including Alzheimer’s.

Researchers at drug maker Eli Lilly report their experimental antibody therapy binds to and literally sweeps away existing plaques in a mouse model of Alzheimer’s.  Their new antibody is part of a trend in so-called immunotherapy in which the body's immune system proteins, or antibodies, can be engineered to target and disable specific disease-causing molecules.

In Eli Lilly's neurodegenerative section, Ronald DeMattos works on new therapies to treat and prevent Alzheimer's disease. “What we’ve been able to demonstrate is that by treatment with this antibody that is very specific to binding to this deposited sticky material… we’re actually able to remove pre-existing clumps or plaque material,” he explained.

In a healthy brain, the protein beta amyloid is normally broken down and eliminated by the body.  But in people with Alzheimer’s, the dissolvable proteins accumulate and form hardened plaques.

Researchers theorize that water-soluble beta amyloid washes over existing plaques, interfering with therapeutic attempts to eliminate the buildup.

Instead of genetically engineering a drug that targeted all of the beta amyloid in an experimental group of mice bred to have Alzheimer’s disease, DeMattos and colleagues developed an antibody that attached to and eliminated only the hardened plaque deposits.

“The antibody is meant literally to enter the brain and help one’s own body facilitate the removal of this deposited plaque material.  And it’s our hope that by doing so, we can hopefully mitigate some of the cognitive deficits that are attributed to the disease,”
DeMattos said.

But it remains to be seen, DeMattos says, whether elimination of hardened Alzheimer’s plaques leads to memory improvements or stops the cognitive decline associated with the disease.

Alzhiemer’s patients typically begin to develop beta amyloid deposits ten or more years before they are diagnosed, according to DeMattos, who says the ultimate goal would be to treat individuals before they develop signs of the disease.

An article on a new antibody therapy for Alzheimer’s disease is published in the journal Neuron.

You May Like

Video Five Patients Given Experimental Ebola Drug Said To Be Improving

Experimental drugs have been tried on six people: three Westerners and now, three African pyhysicians More

Video In Ukraine, Fear and Distrust Remain Where Fighting has Stopped

As Ukrainian military reclaims control of eastern cities residents rebuild their lives, but many say everyone is being treated with suspicion More

Video In Rural Kenya, Pressure Builds Against Female Circumcision

Girls learn to object; FGM practitioners face penalties from jail sentences to stiff fines More

Featured Videos

Your JavaScript is turned off or you have an old version of Adobe's Flash Player. Get the latest Flash player.
Five Patients Given Experimental Ebola Drug Said to Be Improvingi
X
Carol Pearson
August 19, 2014 11:43 PM
The World Health Organization has approved the use of experimental treatments for Ebola patients in West Africa. The Ebola outbreak there is unprecedented, the disease deadly. The number of people who have died from Ebola has surpassed 1,200. VOA's Carol Pearson reports on the ethical considerations of allowing experimental drugs to be used.
Video

Video Five Patients Given Experimental Ebola Drug Said to Be Improving

The World Health Organization has approved the use of experimental treatments for Ebola patients in West Africa. The Ebola outbreak there is unprecedented, the disease deadly. The number of people who have died from Ebola has surpassed 1,200. VOA's Carol Pearson reports on the ethical considerations of allowing experimental drugs to be used.
Video

Video In Ukraine, Fear and Distrust Remain Where Fighting has Stopped

As the Ukrainian military reclaims control of eastern cities from pro-Russian separatists, residents are getting a chance to rebuild their lives. VOA's Gabe Joselow reports from the town of Kramatorsk in Donetsk province, where a sense of fear is still in the air, and distrust of the government in Kyiv still runs deep.
Video

Video China Targets Overseas Assets of Corrupt Officials

As China presses forward with its anti-graft effort, authorities are targeting corrupt officials who have sent family members and assets overseas. The efforts have stirred up a debate at home on exactly how many officials take that route and how likely it is they will be caught. Rebecca Valli has this report.
Video

Video Leading The Fight Against Islamic State, Kurds Question Iraqi Future

Western countries including the United States have begun arming the Kurdish Peshmerga forces in northern Iraq to aid their battle against extremist Sunni militants from the Islamic State. But there are concerns that a heavily-armed Kurdistan Regional Government, or KRG, might seek to declare independence and cause the break-up of the Iraqi state. As Henry Ridgwell reports from London, the KRG says it will only seek greater autonomy from Baghdad.
Video

Video In Rural Kenya, Pressure Builds Against Female Circumcision

In some Kenyan communities, female genital mutilation remains a rite of passage. But activists are pushing back, with education for girls and with threats of punishment those who perform the circumcision. Mohammed Yusuf looks at the practice in the rural eastern community of Tharaka-Nithi.
Video

Video For Obama, Racial Violence is Personal Issue

The racial violence in the St. Louis suburb of Ferguson is presenting U.S. President Barack Obama with an issue to which he has a deep personal connection. To many Americans, Obama's election as America's first black president marked a turning point in race relations in the United States, and Obama has made ending the violence a policy priority. On Monday he issued a new call for calm and understanding. Luis Ramirez reports from the White House.
Video

Video Clinton-Obama Relationship Could Impact 2016 Election

President Barack Obama and former Secretary of State Hillary Clinton have a long and complicated relationship. That relationship took another turn recently when Clinton criticized the president’s foreign policy. VOA National Correspondent Jim Malone reports there is renewed attention on the Clinton-Obama relationship as Hillary Clinton considers running for
Video

Video Iran Looks to Maintain Influence in Baghdad With New Shia PM

Washington and Tehran share the goal of stopping Syrian-based militants in Iraq. But experts say it's Iran, not the United States, that will most influence how the new government in Baghdad approaches internal reforms and the war in Syria. VOA State Department Correspondent Scott Stearns has the story.

AppleAndroid